Hiscox sought to reassure investors on its Covid-19 exposures during its first half earnings call following a 7 percent morning dip in its share price on the back of an $82mn increase in its expected losses from the pandemic.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: